| Market Capitalization (Millions $) |
0 |
| Shares
Outstanding (Millions) |
127 |
| Employees |
54 |
| Revenues (TTM) (Millions $) |
- |
| Net Income (TTM) (Millions $) |
-57 |
| Cash Flow (TTM) (Millions $) |
-30 |
| Capital Exp. (TTM) (Millions $) |
1 |
Business Description
Vaxxinity Inc is a biotechnology company that specializes in the development and production of vaccines for infectious diseases. The company was established in 2016, with its headquarters located in Boston, Massachusetts, USA. The company's main mission is to improve global health by preventing the spread of infectious diseases through the development and distribution of safe and effective vaccines.
Vaxxinity Inc's vaccine development platform combines in-house research with collaborations with academic institutions, government agencies, and industry partners. The company's approach is to develop vaccines that stimulate the body's immune system to fight infectious diseases. They believe that this approach is safer and more effective than traditional methods, such as attenuated or inactivated vaccines.
The company has an impressive portfolio of vaccines that are either in development or already approved for use. Some of the vaccines in their pipeline include vaccines for COVID-19, Zika virus, influenza, and rabies. Vaxxinity Inc's COVID-19 vaccine, VXN-19, is a protein-based vaccine that targets the spike protein of the SARS-CoV-2 virus. The vaccine is currently in phase II clinical trials and has shown promising results in preclinical studies.
Aside from vaccine development, Vaxxinity Inc is also involved in vaccine manufacturing and distribution. The company has partnerships with several contract manufacturing organizations (CMOs) to produce its vaccines in large quantities. They also have collaborations with government agencies, non-profit organizations, and other commercial partners to distribute their vaccines to those who need them the most, particularly in low- and middle-income countries.
Vaxxinity Inc is a relatively new company, but it has already gained recognition in the biotechnology industry for its innovative approach to vaccine development. The company has a team of experienced scientists, researchers, and business executives who are committed to achieving their mission of improving global health through the development of safe and effective vaccines.
Company Address: 505 Odyssey Way Merritt Island 32953 FL
Company Phone Number: 244-5739 Stock Exchange / Ticker: NASDAQ VAXX
|
0.000%
5.59%